0001131096-16-000363.txt : 20160728 0001131096-16-000363.hdr.sgml : 20160728 20160728173345 ACCESSION NUMBER: 0001131096-16-000363 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160727 FILED AS OF DATE: 20160728 DATE AS OF CHANGE: 20160728 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATHENAHEALTH INC CENTRAL INDEX KEY: 0001131096 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 043387530 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-402-1000 MAIL ADDRESS: STREET 1: 311 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANE JOHN A CENTRAL INDEX KEY: 0001049356 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] STATE OF INCORPORATION: VT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33689 FILM NUMBER: 161791208 MAIL ADDRESS: STREET 1: C/O MERCHANTS BANCSHARES, INC. STREET 2: 275 KENNEDY DRIVE CITY: SOUTH BURLINGTON STATE: VT ZIP: 05403 4 1 wf-form4_146974161203201.xml FORM 4 X0306 4 2016-07-27 0 0001131096 ATHENAHEALTH INC ATHN 0001049356 KANE JOHN A C/O ATHENAHEALTH, INC. 311 ARSENAL STREET WATERTOWN MA 02472 1 0 0 0 Common Stock 2016-07-27 4 M 0 2875 15.27 A 10708 D Common Stock 2016-07-27 4 S 0 2875 128.81 D 7833 D Stock Option (Right to Buy) 15.27 2016-07-27 4 M 0 2875 0 D 2007-07-26 2017-07-26 Common Stock 2875.0 6875 D The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.21 to $129.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). /s/ Lan Marinelli Attorney-in-Fact 2016-07-28